Spine Bone Stimulators Market by Product (Non-Invasive and Invasive Spinal Bone Stimulators) and Surgery (Open Spine Surgery and Minimally Invasive Spine Surgery) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

March 2017 | 172 pages | ID: SD3AE24F9D8EN
Allied Market Research

Abstracts

Spine bone stimulators are used during a spinal fusion surgery along with spinal instrumentation (plates, rods, and screws) and bone grafts. Their main function is to enhance the bone’s healing process, which is essential for spinal fusion procedure, and are typically worn after this surgery. A bone stimulator, internal or external, is a small device that delivers low-voltage electrical currents directly to the spinal area where bone growth (spine fusion) is about to occur.
The spine bone stimulators market was valued at $562 million in 2015, and is projected to reach $724 million by 2022, growing at a CAGR of 3.6% from 2016 to 2022. The market is driven by the increase in geriatric population, and rise in incidence of osteoporosis and arthritis. However, advent of bone growth-stimulating drugs, fixation instrumentation during fusion and non-union fractures, and high initial cost of these devices are expected to impede this market growth.

The report segments the spine bone stimulators market based on product type, surgery, and region. On the basis of product type, the market is bifurcated into non-invasive and invasive stimulators. By surgery type, it is divided into open spine surgery and minimally invasive spine surgery. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market has witnessed launch of various spine bone stimulators that are used for spinal fusion. For instance, the product range of Orthofix International NV for bone stimulation has stimulated the market growth. Next-generation bone growth stimulation products-Physio-Stim(R) and Spinal-Stim(R) have empowered the company to increase its market share in the total spine stimulation market.

KEY BENEFITS FOR STAKEHOLDERS

• This report offers an extensive analysis of the current trends and emerging estimations through 2014–2022 of the global spine bone stimulators market, which assist to identify the prevailing opportunities.
• Comprehensive analysis of all geographical regions and factors that drive and restrict the market growth is provided.
• Quantitative analysis of the market from 2014 to 2022 is provided to showcase the financial scenario of the market.
• The market conditions are comprehensively analyzed region- and country-wise.

KEY MARKET SEGMENTS

By Product

• Non-Invasive Spine Bone Stimulators
• Pulsed Electromagnetic Field Device
• Capacitive Coupling(CC) and Combined (Electro) Magnetic Field (CMF) Devices
• Invasive Spine Bone Stimulators

By Surgery

• Open Spine Surgery
• Minimally Invasive Spine Surgery

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• UK
• Spain
• Italy
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

The key companies operating in the spine bone stimulators market that are profiled in the report are as follows:

• Aetna, Inc.
• Bioventus LLC
• DJO Global, Inc.
• elizur Corporation
• IGEA S.p.A.
• Medtronic plc
• Orchid Medical, Inc.
• Orthofix International N.V.
• Ossatec Benelux B.V.
• Smith & Nephew plc
• Verve Consulting Inc.
• Zimmer Biomet Holdings, Inc.

Contents

CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
  3.2.1. Top winning strategies
    3.2.1.1. Competitive intelligence and strategies of companies
  3.2.2. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
  3.4.1. Drivers
    3.4.1.1. Growing elderly population
    3.4.1.2. Increasing prevalence of spinal disorders
    3.4.1.3. Advancements in spine surgery
  3.4.2. Restraints
    3.4.2.1. Availability of substitutes
    3.4.2.2. High initial cost of the device
  3.4.3. Opportunities
    3.4.3.1. Emerging markets to drive the demand for spine bone stimulators
    3.4.3.2. Motion preservation surgery
  3.4.4. Impact analysis
3.5. PORTERS FIVE FORCES ANALYSIS
  3.5.1. Bargaining power of buyers
  3.5.2. Bargaining power of suppliers
  3.5.3. Threat of substitutes
  3.5.4. Threat of new entrants
  3.5.5. Competitive rivalry
3.6. GOVERNMENT REGULATIONS

CHAPTER 4 GLOBAL SPINE BONE STIMULATORS MARKET, BY PRODUCT

4.1. OVERVIEW
  4.1.1. Key market trends
  4.1.2. Growth factors and opportunities
  4.1.3. Market size and forecast
  4.1.4. Global Spinal Bone Stimulator Implantations, By Type
  4.1.5. Non-invasive spine bone stimulators
    4.1.5.1. Market size and forecast
      4.1.5.1.1. Pulsed electromagnetic field device
        4.1.5.1.1.1. Market size and forecast
      4.1.5.1.2. Capacitive coupling and combined magnetic field device
        4.1.5.1.2.1. Market size and forecast
  4.1.6. Invasive spine bone stimulators
    4.1.6.1. Market size and forecast

CHAPTER 5 GLOBAL SPINE BONE STIMULATORS MARKET, BY SURGERY

5.1. OVERVIEW
  5.1.1. Market size and forecast
5.2. OPEN SPINE SURGERY
  5.2.1. Market size and forecast
5.3. MINIMALLY INVASIVE SPINE SURGERY
  5.3.1. Market size and forecast

CHAPTER 6 GLOBAL SPINE BONE STIMULATORS MARKET, BY REGION

6.1. OVERVIEW
  6.1.1. Market size and forecast
6.2. NORTH AMERICA
  6.2.1. Key market trends
  6.2.2. Growth factors and opportunities
  6.2.3. Market size and forecast
  6.2.4. U.S. market size and forecast
  6.2.5. Canada market size and forecast
  6.2.6. Mexico market size and forecast
6.3. EUROPE
  6.3.1. Key market trends
  6.3.2. Growth factors and opportunities
  6.3.3. Market size and forecast
  6.3.4. France market size and forecast
  6.3.5. Germany market size and forecast
  6.3.6. UK market size and forecast
  6.3.7. Spain market size and forecast
  6.3.8. Italy market size and forecast
  6.3.9. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
  6.4.1. Key market trends
  6.4.2. Growth factors and opportunities
  6.4.3. Market size and forecast
  6.4.4. India market size and forecast
  6.4.5. China market size and forecast
  6.4.6. Japan market size and forecast
  6.4.7. South Korea market size and forecast
  6.4.8. Australia market size and forecast
  6.4.9. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
  6.5.1. Key market trends
  6.5.2. Growth factors and opportunities
  6.5.3. Market size and forecast
  6.5.4. Brazil market size and forecast
  6.5.5. Saudi Arabia market size and forecast
  6.5.6. South Africa market size and forecast
  6.5.7. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. AETNA, INC.
  7.1.1. Company overview
  7.1.2. Company snapshot
  7.1.3. Operating product categories
  7.1.4. Business Performance
  7.1.5. Key strategic moves and developments
7.2. BIOVENTUS LLC
  7.2.1. Company overview
  7.2.2. Company snapshot
  7.2.3. Operating business segments
  7.2.4. Business performance
7.3. DJO GLOBAL, INC.
  7.3.1. Company overview
  7.3.2. Company snapshot
  7.3.3. Operating business segments
  7.3.4. Business performance
  7.3.5. Key strategic moves and developments
  7.3.6. Key strategic share
7.4. ELIZUR CORPORATION
  7.4.1. Company overview
  7.4.2. Company snapshot
  7.4.3. Operating business segments
  7.4.4. Business performance
  7.4.5. Key strategic moves and developments
7.5. IGEA S.P.A.
  7.5.1. Company overview
  7.5.2. Company snapshot
  7.5.3. Operating product categories
  7.5.4. Business performance
  7.5.5. Key strategic moves and developments
  7.5.6. Key strategy share
7.6. MEDTRONIC PLC
  7.6.1. Company overview
  7.6.2. Company snapshot
  7.6.3. Operating business segments
  7.6.4. Business performance
  7.6.5. Key strategic moves and developments
  7.6.6. Key strategy share
7.7. ORCHID MEDICAL, INC.
  7.7.1. Company overview
  7.7.2. Company snapshot
  7.7.3. Operating business segments
  7.7.4. Business performance
  7.7.5. Key strategic moves and developments
  7.7.6. Key strategy share
7.8. ORTHOFIX INTERNATIONAL N.V.
  7.8.1. Company overview
  7.8.2. Company snapshot
  7.8.3. Operating business segments
  7.8.4. Business performance
  7.8.5. Key strategic moves and developments, 2014-2016
  7.8.6. Key strategy share, 2014-2016 (%)
7.9. OSSATEC BENELUX B.V.
  7.9.1. Company overview
  7.9.2. Company snapshot
  7.9.3. Operating business segments
  7.9.4. Business performance
  7.9.5. Key strategic moves and developments, 2014-2016
7.10. SMITH & NEPHEW PLC
  7.10.1. Company overview
  7.10.2. Company snapshot
  7.10.3. Operating product categories
  7.10.4. Business performance
  7.10.5. Key strategic moves and developments
  7.10.6. Key strategy share

List Of Tables

LIST OF TABLES

TABLE 1. GLOBAL SPINE BONE STIMULATORS MARKET, BY TYPE ($MILLION), 2014 - 2022
TABLE 2. GLOBAL SPINAL BONE STIMULATOR IMPLANTATIONS, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 3. GLOBAL NON-INVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE ($MILLION), 2014 - 2022
TABLE 4. GLOBAL SPINE BONE STIMULATORS MARKET, BY SURGERY TYPE ($MILLION), 2014-2022
TABLE 5. GLOBAL OPEN SPINE SURGERY MARKET, BY REGION ($MILLION), 2014-2022
TABLE 6. GLOBAL MINIMALLY INVASIVE SPINE SURGERY MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. GLOBAL SPINE BONE STIMULATORS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. NEW PROCEDURE CODES ON THE ASC PAYABLE LIST
TABLE 9. NORTH AMERICA SPINE BONE STIMULATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 10. EUROPE SPINE BONE STIMULATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 11. ASIA-PACIFIC SPINE BONE STIMULATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 12. LAMEA SPINAL IMPLANTS AND DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 13. LAMEA SPINAL FUSION DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 14. LAMEA MOTION PRESERVATION DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 15. LAMEA VCF DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 16. LAMEA SPINE BONE STIMULATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 17. LAMEA SPINE BIOLOGICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 18. ALPHATEC: COMPANY SNAPSHOT
TABLE 19. ALPHATEC: PRODUCT CATEGORIES
TABLE 20. BIOVENTUS: COMPANY SNAPSHOT
TABLE 21. BIOVENTUS: BUSINESS SEGMENTS
TABLE 22. DJO: COMPANY SNAPSHOT
TABLE 23. DJO: BUSINESS SEGMENTS
TABLE 24. ELIZUR: COMPANY SNAPSHOT
TABLE 25. ELIZUR: BUSINESS SEGMENTS
TABLE 26. IGEA: COMPANY SNAPSHOT
TABLE 27. IGEA: PRODUCT CATEGORIES
TABLE 28. MEDTRONIC: COMPANY SNAPSHOT
TABLE 29. MEDTRONIC: BUSINESS SEGMENTS
TABLE 30. ORCHID: COMPANY SNAPSHOT
TABLE 31. ORCHID: BUSINESS SEGMENTS
TABLE 32. ORTHOFIX: COMPANY SNAPSHOT
TABLE 33. ORTHOFIX: BUSINESS SEGMENTS
TABLE 34. OSSATEC: COMPANY SNAPSHOT
TABLE 35. OSSATEC: BUSINESS SEGMENTS
TABLE 36. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 37. SMITH & NEPHEW: BUSINESS SEGMENTS

List Of Figures

LIST OF FIGURES

FIGURE 1. GLOBAL SPINE BONE STIMULATORS MARKET, BY TYPE ($MILLION), 2015 VS 2022
FIGURE 2. MARKET SEGMENTATION
FIGURE 3. TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4. TOP WINNING STRATEGIES, ORGANIC AND INORGANIC
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES
FIGURE 7. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES
FIGURE 8. TOP INVESTMENT POCKETS
FIGURE 9. MARKET SHARE ANALYSIS, 2015
FIGURE 10. LOW BACK PAIN HEALTH CARE VISITS PER 100 PERSONS, U.S., 2010
FIGURE 11. BARGAINING POWER OF BUYERS, 2015
FIGURE 12. BARGAINING POWER OF SUPPLIERS
FIGURE 13. THREAT OF SUBSTITUTES
FIGURE 14. THREAT OF NEW ENTRANTS
FIGURE 15. COMPETITIVE RIVALRY
FIGURE 16. SPINE BONE STIMULATORS MARKET FOR PULSED ELECTROMAGNETIC FIELD DEVICE, 2014-2022 ($MILLION)
FIGURE 17. SPINE BONE STIMULATORS MARKET FOR CAPACITIVE COUPLING & COMBINED MAGNETIC FIELD DEVICES ($MILLION), 2014-2022
FIGURE 18. INVASIVE SPINE BONE STIMULATORS ($MILLION), 2014-2022
FIGURE 19. FUSION PROCEDURES IN THE U.S.
FIGURE 20. DISTRIBUTION OF SPINE FUSION PROCEDURE BY SPINE SECTION FOR HOSPITAL DISCHARGE PATIENTS, U.S., 2011
FIGURE 21. U.S.: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 22. CANADA: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 23. MEXICO: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 24. POPULATION STRUCTURE BY MAJOR AGE GROUPS, EU-28
FIGURE 25. FRANCE: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 26. GERMANY: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 27. UK: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 28. SPAIN: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 29. ITALY: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 30. REST OF EUROPE: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 31. INDIA: SPINE BONE STIMULATORS MARKET ($MILLION), 2014-2022
FIGURE 32. CHINA: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 33. JAPAN: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 34. SOUTH KOREA: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 35. AUSTRALIA: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 36. REST OF ASIA-PACIFIC: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 37. BRAZIL: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 38. SAUDI ARABIA: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 39. SOUTH AFRICA: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022
FIGURE 40. REST OF LAMEA: SPINAL IMPLANTS AND DEVICES MARKET ($MILLION), 2014-2022